Pamgene International B.V.

's-Hertogenbosch, NB

UEI
DVBJJ8WMJ3M3
CAGE
H2ES7
Primary NAICS
541380 Testing Laboratories and Services
SAM.gov registration
Active through

Company facts

Self-certified in SAM.gov
  • For Profit Organization
  • Limited Liability Company
  • Manufacturer of Goods
Entity structure
International Organization
SAM.gov registration date
Physical address
Wolvenhoek 10, 5211 HH 's-Hertogenbosch, Netherlands
Website
pamgene.com
Founded
2000
Employees
11-50
Estimated annual revenue
$1M-$10M
Industry
  1. Health Care
  2. Pharmaceuticals, Biotechnology & Life Sciences
  3. Biotechnology
SIC code
87 Engineering & Management Services
Profiles

Registration and certifications come from SAM.gov and the SBA; company details from public web sources. Updated .

Contract awards

Award Agency Obligated Awarded
Kinome activity profiling to gain more insights into the adaptive resistance mechanism of rhabdomyosarcoma (RMS) cell… 75N91022P00264 National Cancer Institute (NIH) $14,950
Tyrosine and serine/threonine kinase activity profiling 75N91021P00442 National Cancer Institute (NIH) $14,000
Pamgene international B.V. FXR environmental chemical marconi profiling pilot HHSN271201500138P National Institute on Drug Abuse (NIH) $9,800
Study-pamgene HHSN273201300041P National Institute of Environmental Health Sciences (NIH) $5,990

Quick answers

Is Pamgene International B.V. registered in SAM.gov?

Yes. Pamgene International B.V.'s SAM.gov registration is active through December 22, 2026.

What is Pamgene International B.V.'s most recent federal award?

Pamgene International B.V.'s most recent federal contract award is Kinome activity profiling to gain more insights into the adaptive resistance mechanism of rhabdomyosarcoma (RMS) cell… (75N91022P00264), from National Cancer Institute (NIH), on February 14, 2022.

On GovTribe

See Pamgene International B.V.'s full federal record

  • Federal contract awards
  • Funding analysis by agency, NAICS and set-aside
  • Similar vendors
Try for free Login